The objective of this @-day study was to evaluate the ocular hypotensive efficacy and safety of AR-@ ophthalmic solution compared with a positive control , latanoprost ophthalmic solution , in patients with open-angle glaucoma ( OAG ) or ocular hypertension ( OHT ) .